Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Piramal Enterprises Ltd.
DescriptionOrally active free fatty acid receptor 1 (FFARI; GPR40) agonist
Molecular Target Free fatty acid receptor 1 (FFAR1) (GPR40)
Mechanism of ActionFree fatty acid receptor 1 (FFARI; GPR40) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today